Report Overview
This report provides a deep insight into the global Personalized Medicine and Epigenomics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Personalized Medicine and Epigenomics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Personalized Medicine and Epigenomics market in any manner.
Global Personalized Medicine and Epigenomics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
Affymetrix
Agilent Technologies
Astellas Pharmaceuticals
BAYER AG
Bio Vision
Celgene Corp.
Emd Millipore
Epigenomics AG
Epigentex
Envivo Pharmaceuticals (Forum Pharmaceutricals)
Gilead Sciences
Glaxosmithkline
Illumina Inc.
Johnson & Johnson
Karus Therapeutics Limited
Laboratory Corp. Of America Holdings
LES Laboratoires Servier
Merck
Naturewise Biotech & Medicals Corp.
Novartis Pharma AG
Oncolys Biopharma Inc.
Orchid Chemicals & Pharmaceuticals Limited
Progen Pharmaceuticals Limited
Quest Diagnostics
Roche Holding AG
Rubicon Genomics
Takeda Pharmaceutical Company Limited
Market Segmentation (by Type)
Reagents
Kits
Instruments
Enzymes
Services
Market Segmentation (by Application)
Oncology
Non-Oncology
Cancer Drug Technology
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Personalized Medicine and Epigenomics Market
? Overview of the regional outlook of the Personalized Medicine and Epigenomics Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Personalized Medicine and Epigenomics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Personalized Medicine and Epigenomics
1.2 Key Market Segments
1.2.1 Personalized Medicine and Epigenomics Segment by Type
1.2.2 Personalized Medicine and Epigenomics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Personalized Medicine and Epigenomics Market Overview
2.1 Global Market Overview
2.1.1 Global Personalized Medicine and Epigenomics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Personalized Medicine and Epigenomics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Personalized Medicine and Epigenomics Market Competitive Landscape
3.1 Global Personalized Medicine and Epigenomics Sales by Manufacturers (2019-2024)
3.2 Global Personalized Medicine and Epigenomics Revenue Market Share by Manufacturers (2019-2024)
3.3 Personalized Medicine and Epigenomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Personalized Medicine and Epigenomics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Personalized Medicine and Epigenomics Sales Sites, Area Served, Product Type
3.6 Personalized Medicine and Epigenomics Market Competitive Situation and Trends
3.6.1 Personalized Medicine and Epigenomics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Personalized Medicine and Epigenomics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Personalized Medicine and Epigenomics Industry Chain Analysis
4.1 Personalized Medicine and Epigenomics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Personalized Medicine and Epigenomics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Personalized Medicine and Epigenomics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Personalized Medicine and Epigenomics Sales Market Share by Type (2019-2024)
6.3 Global Personalized Medicine and Epigenomics Market Size Market Share by Type (2019-2024)
6.4 Global Personalized Medicine and Epigenomics Price by Type (2019-2024)
7 Personalized Medicine and Epigenomics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Personalized Medicine and Epigenomics Market Sales by Application (2019-2024)
7.3 Global Personalized Medicine and Epigenomics Market Size (M USD) by Application (2019-2024)
7.4 Global Personalized Medicine and Epigenomics Sales Growth Rate by Application (2019-2024)
8 Personalized Medicine and Epigenomics Market Segmentation by Region
8.1 Global Personalized Medicine and Epigenomics Sales by Region
8.1.1 Global Personalized Medicine and Epigenomics Sales by Region
8.1.2 Global Personalized Medicine and Epigenomics Sales Market Share by Region
8.2 North America
8.2.1 North America Personalized Medicine and Epigenomics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Personalized Medicine and Epigenomics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Personalized Medicine and Epigenomics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Personalized Medicine and Epigenomics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Personalized Medicine and Epigenomics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Personalized Medicine and Epigenomics Basic Information
9.1.2 Abbott Laboratories Personalized Medicine and Epigenomics Product Overview
9.1.3 Abbott Laboratories Personalized Medicine and Epigenomics Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Personalized Medicine and Epigenomics SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Affymetrix
9.2.1 Affymetrix Personalized Medicine and Epigenomics Basic Information
9.2.2 Affymetrix Personalized Medicine and Epigenomics Product Overview
9.2.3 Affymetrix Personalized Medicine and Epigenomics Product Market Performance
9.2.4 Affymetrix Business Overview
9.2.5 Affymetrix Personalized Medicine and Epigenomics SWOT Analysis
9.2.6 Affymetrix Recent Developments
9.3 Agilent Technologies
9.3.1 Agilent Technologies Personalized Medicine and Epigenomics Basic Information
9.3.2 Agilent Technologies Personalized Medicine and Epigenomics Product Overview
9.3.3 Agilent Technologies Personalized Medicine and Epigenomics Product Market Performance
9.3.4 Agilent Technologies Personalized Medicine and Epigenomics SWOT Analysis
9.3.5 Agilent Technologies Business Overview
9.3.6 Agilent Technologies Recent Developments
9.4 Astellas Pharmaceuticals
9.4.1 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Basic Information
9.4.2 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product Overview
9.4.3 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product Market Performance
9.4.4 Astellas Pharmaceuticals Business Overview
9.4.5 Astellas Pharmaceuticals Recent Developments
9.5 BAYER AG
9.5.1 BAYER AG Personalized Medicine and Epigenomics Basic Information
9.5.2 BAYER AG Personalized Medicine and Epigenomics Product Overview
9.5.3 BAYER AG Personalized Medicine and Epigenomics Product Market Performance
9.5.4 BAYER AG Business Overview
9.5.5 BAYER AG Recent Developments
9.6 Bio Vision
9.6.1 Bio Vision Personalized Medicine and Epigenomics Basic Information
9.6.2 Bio Vision Personalized Medicine and Epigenomics Product Overview
9.6.3 Bio Vision Personalized Medicine and Epigenomics Product Market Performance
9.6.4 Bio Vision Business Overview
9.6.5 Bio Vision Recent Developments
9.7 Celgene Corp.
9.7.1 Celgene Corp. Personalized Medicine and Epigenomics Basic Information
9.7.2 Celgene Corp. Personalized Medicine and Epigenomics Product Overview
9.7.3 Celgene Corp. Personalized Medicine and Epigenomics Product Market Performance
9.7.4 Celgene Corp. Business Overview
9.7.5 Celgene Corp. Recent Developments
9.8 Emd Millipore
9.8.1 Emd Millipore Personalized Medicine and Epigenomics Basic Information
9.8.2 Emd Millipore Personalized Medicine and Epigenomics Product Overview
9.8.3 Emd Millipore Personalized Medicine and Epigenomics Product Market Performance
9.8.4 Emd Millipore Business Overview
9.8.5 Emd Millipore Recent Developments
9.9 Epigenomics AG
9.9.1 Epigenomics AG Personalized Medicine and Epigenomics Basic Information
9.9.2 Epigenomics AG Personalized Medicine and Epigenomics Product Overview
9.9.3 Epigenomics AG Personalized Medicine and Epigenomics Product Market Performance
9.9.4 Epigenomics AG Business Overview
9.9.5 Epigenomics AG Recent Developments
9.10 Epigentex
9.10.1 Epigentex Personalized Medicine and Epigenomics Basic Information
9.10.2 Epigentex Personalized Medicine and Epigenomics Product Overview
9.10.3 Epigentex Personalized Medicine and Epigenomics Product Market Performance
9.10.4 Epigentex Business Overview
9.10.5 Epigentex Recent Developments
9.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
9.11.1 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Basic Information
9.11.2 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product Overview
9.11.3 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product Market Performance
9.11.4 Envivo Pharmaceuticals (Forum Pharmaceutricals) Business Overview
9.11.5 Envivo Pharmaceuticals (Forum Pharmaceutricals) Recent Developments
9.12 Gilead Sciences
9.12.1 Gilead Sciences Personalized Medicine and Epigenomics Basic Information
9.12.2 Gilead Sciences Personalized Medicine and Epigenomics Product Overview
9.12.3 Gilead Sciences Personalized Medicine and Epigenomics Product Market Performance
9.12.4 Gilead Sciences Business Overview
9.12.5 Gilead Sciences Recent Developments
9.13 Glaxosmithkline
9.13.1 Glaxosmithkline Personalized Medicine and Epigenomics Basic Information
9.13.2 Glaxosmithkline Personalized Medicine and Epigenomics Product Overview
9.13.3 Glaxosmithkline Personalized Medicine and Epigenomics Product Market Performance
9.13.4 Glaxosmithkline Business Overview
9.13.5 Glaxosmithkline Recent Developments
9.14 Illumina Inc.
9.14.1 Illumina Inc. Personalized Medicine and Epigenomics Basic Information
9.14.2 Illumina Inc. Personalized Medicine and Epigenomics Product Overview
9.14.3 Illumina Inc. Personalized Medicine and Epigenomics Product Market Performance
9.14.4 Illumina Inc. Business Overview
9.14.5 Illumina Inc. Recent Developments
9.15 Johnson and Johnson
9.15.1 Johnson and Johnson Personalized Medicine and Epigenomics Basic Information
9.15.2 Johnson and Johnson Personalized Medicine and Epigenomics Product Overview
9.15.3 Johnson and Johnson Personalized Medicine and Epigenomics Product Market Performance
9.15.4 Johnson and Johnson Business Overview
9.15.5 Johnson and Johnson Recent Developments
9.16 Karus Therapeutics Limited
9.16.1 Karus Therapeutics Limited Personalized Medicine and Epigenomics Basic Information
9.16.2 Karus Therapeutics Limited Personalized Medicine and Epigenomics Product Overview
9.16.3 Karus Therapeutics Limited Personalized Medicine and Epigenomics Product Market Performance
9.16.4 Karus Therapeutics Limited Business Overview
9.16.5 Karus Therapeutics Limited Recent Developments
9.17 Laboratory Corp. Of America Holdings
9.17.1 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Basic Information
9.17.2 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product Overview
9.17.3 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product Market Performance
9.17.4 Laboratory Corp. Of America Holdings Business Overview
9.17.5 Laboratory Corp. Of America Holdings Recent Developments
9.18 LES Laboratoires Servier
9.18.1 LES Laboratoires Servier Personalized Medicine and Epigenomics Basic Information
9.18.2 LES Laboratoires Servier Personalized Medicine and Epigenomics Product Overview
9.18.3 LES Laboratoires Servier Personalized Medicine and Epigenomics Product Market Performance
9.18.4 LES Laboratoires Servier Business Overview
9.18.5 LES Laboratoires Servier Recent Developments
9.19 Merck
9.19.1 Merck Personalized Medicine and Epigenomics Basic Information
9.19.2 Merck Personalized Medicine and Epigenomics Product Overview
9.19.3 Merck Personalized Medicine and Epigenomics Product Market Performance
9.19.4 Merck Business Overview
9.19.5 Merck Recent Developments
9.20 Naturewise Biotech and Medicals Corp.
9.20.1 Naturewise Biotech and Medicals Corp. Personalized Medicine and Epigenomics Basic Information
9.20.2 Naturewise Biotech and Medicals Corp. Personalized Medicine and Epigenomics Product Overview
9.20.3 Naturewise Biotech and Medicals Corp. Personalized Medicine and Epigenomics Product Market Performance
9.20.4 Naturewise Biotech and Medicals Corp. Business Overview
9.20.5 Naturewise Biotech and Medicals Corp. Recent Developments
9.21 Novartis Pharma AG
9.21.1 Novartis Pharma AG Personalized Medicine and Epigenomics Basic Information
9.21.2 Novartis Pharma AG Personalized Medicine and Epigenomics Product Overview
9.21.3 Novartis Pharma AG Personalized Medicine and Epigenomics Product Market Performance
9.21.4 Novartis Pharma AG Business Overview
9.21.5 Novartis Pharma AG Recent Developments
9.22 Oncolys Biopharma Inc.
9.22.1 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Basic Information
9.22.2 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product Overview
9.22.3 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product Market Performance
9.22.4 Oncolys Biopharma Inc. Business Overview
9.22.5 Oncolys Biopharma Inc. Recent Developments
9.23 Orchid Chemicals and Pharmaceuticals Limited
9.23.1 Orchid Chemicals and Pharmaceuticals Limited Personalized Medicine and Epigenomics Basic Information
9.23.2 Orchid Chemicals and Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Overview
9.23.3 Orchid Chemicals and Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Market Performance
9.23.4 Orchid Chemicals and Pharmaceuticals Limited Business Overview
9.23.5 Orchid Chemicals and Pharmaceuticals Limited Recent Developments
9.24 Progen Pharmaceuticals Limited
9.24.1 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Basic Information
9.24.2 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Overview
9.24.3 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Market Performance
9.24.4 Progen Pharmaceuticals Limited Business Overview
9.24.5 Progen Pharmaceuticals Limited Recent Developments
9.25 Quest Diagnostics
9.25.1 Quest Diagnostics Personalized Medicine and Epigenomics Basic Information
9.25.2 Quest Diagnostics Personalized Medicine and Epigenomics Product Overview
9.25.3 Quest Diagnostics Personalized Medicine and Epigenomics Product Market Performance
9.25.4 Quest Diagnostics Business Overview
9.25.5 Quest Diagnostics Recent Developments
9.26 Roche Holding AG
9.26.1 Roche Holding AG Personalized Medicine and Epigenomics Basic Information
9.26.2 Roche Holding AG Personalized Medicine and Epigenomics Product Overview
9.26.3 Roche Holding AG Personalized Medicine and Epigenomics Product Market Performance
9.26.4 Roche Holding AG Business Overview
9.26.5 Roche Holding AG Recent Developments
9.27 Rubicon Genomics
9.27.1 Rubicon Genomics Personalized Medicine and Epigenomics Basic Information
9.27.2 Rubicon Genomics Personalized Medicine and Epigenomics Product Overview
9.27.3 Rubicon Genomics Personalized Medicine and Epigenomics Product Market Performance
9.27.4 Rubicon Genomics Business Overview
9.27.5 Rubicon Genomics Recent Developments
9.28 Takeda Pharmaceutical Company Limited
9.28.1 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Basic Information
9.28.2 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product Overview
9.28.3 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product Market Performance
9.28.4 Takeda Pharmaceutical Company Limited Business Overview
9.28.5 Takeda Pharmaceutical Company Limited Recent Developments
10 Personalized Medicine and Epigenomics Market Forecast by Region
10.1 Global Personalized Medicine and Epigenomics Market Size Forecast
10.2 Global Personalized Medicine and Epigenomics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Personalized Medicine and Epigenomics Market Size Forecast by Country
10.2.3 Asia Pacific Personalized Medicine and Epigenomics Market Size Forecast by Region
10.2.4 South America Personalized Medicine and Epigenomics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Personalized Medicine and Epigenomics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Personalized Medicine and Epigenomics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Personalized Medicine and Epigenomics by Type (2025-2030)
11.1.2 Global Personalized Medicine and Epigenomics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Personalized Medicine and Epigenomics by Type (2025-2030)
11.2 Global Personalized Medicine and Epigenomics Market Forecast by Application (2025-2030)
11.2.1 Global Personalized Medicine and Epigenomics Sales (K Units) Forecast by Application
11.2.2 Global Personalized Medicine and Epigenomics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Personalized Medicine and Epigenomics Market Size Comparison by Region (M USD)
Table 5. Global Personalized Medicine and Epigenomics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Personalized Medicine and Epigenomics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Personalized Medicine and Epigenomics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Personalized Medicine and Epigenomics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine and Epigenomics as of 2022)
Table 10. Global Market Personalized Medicine and Epigenomics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Personalized Medicine and Epigenomics Sales Sites and Area Served
Table 12. Manufacturers Personalized Medicine and Epigenomics Product Type
Table 13. Global Personalized Medicine and Epigenomics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Personalized Medicine and Epigenomics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Personalized Medicine and Epigenomics Market Challenges
Table 22. Global Personalized Medicine and Epigenomics Sales by Type (K Units)
Table 23. Global Personalized Medicine and Epigenomics Market Size by Type (M USD)
Table 24. Global Personalized Medicine and Epigenomics Sales (K Units) by Type (2019-2024)
Table 25. Global Personalized Medicine and Epigenomics Sales Market Share by Type (2019-2024)
Table 26. Global Personalized Medicine and Epigenomics Market Size (M USD) by Type (2019-2024)
Table 27. Global Personalized Medicine and Epigenomics Market Size Share by Type (2019-2024)
Table 28. Global Personalized Medicine and Epigenomics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Personalized Medicine and Epigenomics Sales (K Units) by Application
Table 30. Global Personalized Medicine and Epigenomics Market Size by Application
Table 31. Global Personalized Medicine and Epigenomics Sales by Application (2019-2024) & (K Units)
Table 32. Global Personalized Medicine and Epigenomics Sales Market Share by Application (2019-2024)
Table 33. Global Personalized Medicine and Epigenomics Sales by Application (2019-2024) & (M USD)
Table 34. Global Personalized Medicine and Epigenomics Market Share by Application (2019-2024)
Table 35. Global Personalized Medicine and Epigenomics Sales Growth Rate by Application (2019-2024)
Table 36. Global Personalized Medicine and Epigenomics Sales by Region (2019-2024) & (K Units)
Table 37. Global Personalized Medicine and Epigenomics Sales Market Share by Region (2019-2024)
Table 38. North America Personalized Medicine and Epigenomics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Personalized Medicine and Epigenomics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Personalized Medicine and Epigenomics Sales by Region (2019-2024) & (K Units)
Table 41. South America Personalized Medicine and Epigenomics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Personalized Medicine and Epigenomics Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Laboratories Personalized Medicine and Epigenomics Basic Information
Table 44. Abbott Laboratories Personalized Medicine and Epigenomics Product Overview
Table 45. Abbott Laboratories Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Laboratories Business Overview
Table 47. Abbott Laboratories Personalized Medicine and Epigenomics SWOT Analysis
Table 48. Abbott Laboratories Recent Developments
Table 49. Affymetrix Personalized Medicine and Epigenomics Basic Information
Table 50. Affymetrix Personalized Medicine and Epigenomics Product Overview
Table 51. Affymetrix Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Affymetrix Business Overview
Table 53. Affymetrix Personalized Medicine and Epigenomics SWOT Analysis
Table 54. Affymetrix Recent Developments
Table 55. Agilent Technologies Personalized Medicine and Epigenomics Basic Information
Table 56. Agilent Technologies Personalized Medicine and Epigenomics Product Overview
Table 57. Agilent Technologies Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Agilent Technologies Personalized Medicine and Epigenomics SWOT Analysis
Table 59. Agilent Technologies Business Overview
Table 60. Agilent Technologies Recent Developments
Table 61. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Basic Information
Table 62. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product Overview
Table 63. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Astellas Pharmaceuticals Business Overview
Table 65. Astellas Pharmaceuticals Recent Developments
Table 66. BAYER AG Personalized Medicine and Epigenomics Basic Information
Table 67. BAYER AG Personalized Medicine and Epigenomics Product Overview
Table 68. BAYER AG Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BAYER AG Business Overview
Table 70. BAYER AG Recent Developments
Table 71. Bio Vision Personalized Medicine and Epigenomics Basic Information
Table 72. Bio Vision Personalized Medicine and Epigenomics Product Overview
Table 73. Bio Vision Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bio Vision Business Overview
Table 75. Bio Vision Recent Developments
Table 76. Celgene Corp. Personalized Medicine and Epigenomics Basic Information
Table 77. Celgene Corp. Personalized Medicine and Epigenomics Product Overview
Table 78. Celgene Corp. Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Celgene Corp. Business Overview
Table 80. Celgene Corp. Recent Developments
Table 81. Emd Millipore Personalized Medicine and Epigenomics Basic Information
Table 82. Emd Millipore Personalized Medicine and Epigenomics Product Overview
Table 83. Emd Millipore Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Emd Millipore Business Overview
Table 85. Emd Millipore Recent Developments
Table 86. Epigenomics AG Personalized Medicine and Epigenomics Basic Information
Table 87. Epigenomics AG Personalized Medicine and Epigenomics Product Overview
Table 88. Epigenomics AG Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Epigenomics AG Business Overview
Table 90. Epigenomics AG Recent Developments
Table 91. Epigentex Personalized Medicine and Epigenomics Basic Information
Table 92. Epigentex Personalized Medicine and Epigenomics Product Overview
Table 93. Epigentex Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Epigentex Business Overview
Table 95. Epigentex Recent Developments
Table 96. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Basic Information
Table 97. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product Overview
Table 98. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Envivo Pharmaceuticals (Forum Pharmaceutricals) Business Overview
Table 100. Envivo Pharmaceuticals (Forum Pharmaceutricals) Recent Developments
Table 101. Gilead Sciences Personalized Medicine and Epigenomics Basic Information
Table 102. Gilead Sciences Personalized Medicine and Epigenomics Product Overview
Table 103. Gilead Sciences Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Gilead Sciences Business Overview
Table 105. Gilead Sciences Recent Developments
Table 106. Glaxosmithkline Personalized Medicine and Epigenomics Basic Information
Table 107. Glaxosmithkline Personalized Medicine and Epigenomics Product Overview
Table 108. Glaxosmithkline Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Glaxosmithkline Business Overview
Table 110. Glaxosmithkline Recent Developments
Table 111. Illumina Inc. Personalized Medicine and Epigenomics Basic Information
Table 112. Illumina Inc. Personalized Medicine and Epigenomics Product Overview
Table 113. Illumina Inc. Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Illumina Inc. Business Overview
Table 115. Illumina Inc. Recent Developments
Table 116. Johnson and Johnson Personalized Medicine and Epigenomics Basic Information
Table 117. Johnson and Johnson Personalized Medicine and Epigenomics Product Overview
Table 118. Johnson and Johnson Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Johnson and Johnson Business Overview
Table 120. Johnson and Johnson Recent Developments
Table 121. Karus Therapeutics Limited Personalized Medicine and Epigenomics Basic Information
Table 122. Karus Therapeutics Limited Personalized Medicine and Epigenomics Product Overview
Table 123. Karus Therapeutics Limited Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Karus Therapeutics Limited Business Overview
Table 125. Karus Therapeutics Limited Recent Developments
Table 126. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Basic Information
Table 127. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product Overview
Table 128. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Laboratory Corp. Of America Holdings Business Overview
Table 130. Laboratory Corp. Of America Holdings Recent Developments
Table 131. LES Laboratoires Servier Personalized Medicine and Epigenomics Basic Information
Table 132. LES Laboratoires Servier Personalized Medicine and Epigenomics Product Overview
Table 133. LES Laboratoires Servier Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. LES Laboratoires Servier Business Overview
Table 135. LES Laboratoires Servier Recent Developments
Table 136. Merck Personalized Medicine and Epigenomics Basic Information
Table 137. Merck Personalized Medicine and Epigenomics Product Overview
Table 138. Merck Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Merck Business Overview
Table 140. Merck Recent Developments
Table 141. Naturewise Biotech and Medicals Corp. Personalized Medicine and Epigenomics Basic Information
Table 142. Naturewise Biotech and Medicals Corp. Personalized Medicine and Epigenomics Product Overview
Table 143. Naturewise Biotech and Medicals Corp. Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Naturewise Biotech and Medicals Corp. Business Overview
Table 145. Naturewise Biotech and Medicals Corp. Recent Developments
Table 146. Novartis Pharma AG Personalized Medicine and Epigenomics Basic Information
Table 147. Novartis Pharma AG Personalized Medicine and Epigenomics Product Overview
Table 148. Novartis Pharma AG Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Novartis Pharma AG Business Overview
Table 150. Novartis Pharma AG Recent Developments
Table 151. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Basic Information
Table 152. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product Overview
Table 153. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Oncolys Biopharma Inc. Business Overview
Table 155. Oncolys Biopharma Inc. Recent Developments
Table 156. Orchid Chemicals and Pharmaceuticals Limited Personalized Medicine and Epigenomics Basic Information
Table 157. Orchid Chemicals and Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Overview
Table 158. Orchid Chemicals and Pharmaceuticals Limited Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Orchid Chemicals and Pharmaceuticals Limited Business Overview
Table 160. Orchid Chemicals and Pharmaceuticals Limited Recent Developments
Table 161. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Basic Information
Table 162. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product Overview
Table 163. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Progen Pharmaceuticals Limited Business Overview
Table 165. Progen Pharmaceuticals Limited Recent Developments
Table 166. Quest Diagnostics Personalized Medicine and Epigenomics Basic Information
Table 167. Quest Diagnostics Personalized Medicine and Epigenomics Product Overview
Table 168. Quest Diagnostics Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Quest Diagnostics Business Overview
Table 170. Quest Diagnostics Recent Developments
Table 171. Roche Holding AG Personalized Medicine and Epigenomics Basic Information
Table 172. Roche Holding AG Personalized Medicine and Epigenomics Product Overview
Table 173. Roche Holding AG Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Roche Holding AG Business Overview
Table 175. Roche Holding AG Recent Developments
Table 176. Rubicon Genomics Personalized Medicine and Epigenomics Basic Information
Table 177. Rubicon Genomics Personalized Medicine and Epigenomics Product Overview
Table 178. Rubicon Genomics Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Rubicon Genomics Business Overview
Table 180. Rubicon Genomics Recent Developments
Table 181. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Basic Information
Table 182. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product Overview
Table 183. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 184. Takeda Pharmaceutical Company Limited Business Overview
Table 185. Takeda Pharmaceutical Company Limited Recent Developments
Table 186. Global Personalized Medicine and Epigenomics Sales Forecast by Region (2025-2030) & (K Units)
Table 187. Global Personalized Medicine and Epigenomics Market Size Forecast by Region (2025-2030) & (M USD)
Table 188. North America Personalized Medicine and Epigenomics Sales Forecast by Country (2025-2030) & (K Units)
Table 189. North America Personalized Medicine and Epigenomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 190. Europe Personalized Medicine and Epigenomics Sales Forecast by Country (2025-2030) & (K Units)
Table 191. Europe Personalized Medicine and Epigenomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 192. Asia Pacific Personalized Medicine and Epigenomics Sales Forecast by Region (2025-2030) & (K Units)
Table 193. Asia Pacific Personalized Medicine and Epigenomics Market Size Forecast by Region (2025-2030) & (M USD)
Table 194. South America Personalized Medicine and Epigenomics Sales Forecast by Country (2025-2030) & (K Units)
Table 195. South America Personalized Medicine and Epigenomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 196. Middle East and Africa Personalized Medicine and Epigenomics Consumption Forecast by Country (2025-2030) & (Units)
Table 197. Middle East and Africa Personalized Medicine and Epigenomics Market Size Forecast by Country (2025-2030) & (M USD)
Table 198. Global Personalized Medicine and Epigenomics Sales Forecast by Type (2025-2030) & (K Units)
Table 199. Global Personalized Medicine and Epigenomics Market Size Forecast by Type (2025-2030) & (M USD)
Table 200. Global Personalized Medicine and Epigenomics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 201. Global Personalized Medicine and Epigenomics Sales (K Units) Forecast by Application (2025-2030)
Table 202. Global Personalized Medicine and Epigenomics Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Personalized Medicine and Epigenomics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Personalized Medicine and Epigenomics Market Size (M USD), 2019-2030
Figure 5. Global Personalized Medicine and Epigenomics Market Size (M USD) (2019-2030)
Figure 6. Global Personalized Medicine and Epigenomics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Personalized Medicine and Epigenomics Market Size by Country (M USD)
Figure 11. Personalized Medicine and Epigenomics Sales Share by Manufacturers in 2023
Figure 12. Global Personalized Medicine and Epigenomics Revenue Share by Manufacturers in 2023
Figure 13. Personalized Medicine and Epigenomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Personalized Medicine and Epigenomics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Personalized Medicine and Epigenomics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Personalized Medicine and Epigenomics Market Share by Type
Figure 18. Sales Market Share of Personalized Medicine and Epigenomics by Type (2019-2024)
Figure 19. Sales Market Share of Personalized Medicine and Epigenomics by Type in 2023
Figure 20. Market Size Share of Personalized Medicine and Epigenomics by Type (2019-2024)
Figure 21. Market Size Market Share of Personalized Medicine and Epigenomics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Personalized Medicine and Epigenomics Market Share by Application
Figure 24. Global Personalized Medicine and Epigenomics Sales Market Share by Application (2019-2024)
Figure 25. Global Personalized Medicine and Epigenomics Sales Market Share by Application in 2023
Figure 26. Global Personalized Medicine and Epigenomics Market Share by Application (2019-2024)
Figure 27. Global Personalized Medicine and Epigenomics Market Share by Application in 2023
Figure 28. Global Personalized Medicine and Epigenomics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Personalized Medicine and Epigenomics Sales Market Share by Region (2019-2024)
Figure 30. North America Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Personalized Medicine and Epigenomics Sales Market Share by Country in 2023
Figure 32. U.S. Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Personalized Medicine and Epigenomics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Personalized Medicine and Epigenomics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Personalized Medicine and Epigenomics Sales Market Share by Country in 2023
Figure 37. Germany Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Personalized Medicine and Epigenomics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Personalized Medicine and Epigenomics Sales Market Share by Region in 2023
Figure 44. China Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Personalized Medicine and Epigenomics Sales and Growth Rate (K Units)
Figure 50. South America Personalized Medicine and Epigenomics Sales Market Share by Country in 2023
Figure 51. Brazil Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Personalized Medicine and Epigenomics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Personalized Medicine and Epigenomics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Personalized Medicine and Epigenomics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Personalized Medicine and Epigenomics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Personalized Medicine and Epigenomics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Personalized Medicine and Epigenomics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Personalized Medicine and Epigenomics Market Share Forecast by Type (2025-2030)
Figure 65. Global Personalized Medicine and Epigenomics Sales Forecast by Application (2025-2030)
Figure 66. Global Personalized Medicine and Epigenomics Market Share Forecast by Application (2025-2030)
